Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
12/28/2000 | WO2000078793A2 Antimicrobial agents |
12/28/2000 | WO2000078344A1 Prion protein peptides and uses thereof |
12/28/2000 | WO2000056353A3 A uro-genital condition treatment system |
12/28/2000 | WO2000017369B1 Alzheimer's disease secretase |
12/28/2000 | CA2377648A1 Prion protein peptides and uses thereof |
12/28/2000 | CA2376081A1 Cysteinyl protease inhibitors |
12/28/2000 | CA2375229A1 Method and compounds for inhibiting activity of serine elastases |
12/28/2000 | CA2276542A1 Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
12/27/2000 | EP1062949A1 IgE ANTIBODY PRODUCTION INHIBITORS AND AUTOIMMUNE DISEASES INHIBITORS |
12/27/2000 | EP1062878A1 Mixed crystals comprising aspartame and aspartame derivative and process for producing the same |
12/27/2000 | EP1062231A1 Process for the preparation of a tetrapeptide |
12/27/2000 | EP1062229A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
12/27/2000 | EP1061937A1 Improved radiation therapy methods |
12/27/2000 | EP1061936A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders |
12/27/2000 | EP0751768B1 Anti-viral and anti-cancer agent |
12/27/2000 | CN1278244A Dipeptide nitriles |
12/27/2000 | CN1277961A Novel 2,3-methylene amino acid compound, prepn. method therefor, pharmaceutical compositions contg. same |
12/26/2000 | US6166217 Process for the production of alkoxycarbonyldipeptides intermediates in the synthesis of the lisinopril |
12/26/2000 | US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents |
12/26/2000 | US6166086 Small molecules that increase the conversion of food to body weight gain |
12/26/2000 | US6165717 Method of synthesizing diverse collections of oligomers |
12/26/2000 | CA2182476C Macrocyclic difluorostatone derivatives useful as antiviral agents |
12/26/2000 | CA2127067C Phosphonic acid derivatives, their preparation process and pharmaceutical compositions containing them |
12/21/2000 | WO2000077184A1 Caspase-8 crystals, models and methods |
12/21/2000 | WO2000077032A2 Spermine:peptide-based surfactant compounds |
12/21/2000 | WO2000077030A1 Statine-derived tetrapeptide inhibitors of beta-secretase |
12/21/2000 | WO2000076504A1 Production of agglomerates of inogatran and the compound inogatran anhydrate |
12/21/2000 | WO2000044366A3 Therapeutic compositions containing glutathione analogs |
12/21/2000 | CA2376420A1 Statine-derived tetrapeptide inhibitors of beta-secretase |
12/20/2000 | EP1060190A1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide |
12/20/2000 | EP1059919A1 Small molecules that increase the conversion of food to body weight gain |
12/20/2000 | EP0830371B1 IMIDAZO(1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS |
12/20/2000 | EP0823848A4 Tissue adhesive using synthetic cross-linking |
12/20/2000 | EP0753526B1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient |
12/19/2000 | US6162828 Cysteine protease inhibitor |
12/19/2000 | US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use |
12/19/2000 | US6162800 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
12/19/2000 | US6162791 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
12/19/2000 | US6162790 Oligopeptides |
12/19/2000 | US6162783 Liquid detergents containing proteolytic enzyme and protease inhibitors |
12/19/2000 | US6162434 Cytomodulating peptide for inhibiting lymphocyte activity |
12/19/2000 | CA2189527C Novel elastase inhibitors |
12/14/2000 | WO2000075365A2 Compounds and methods to enhance raav transduction |
12/14/2000 | WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof |
12/14/2000 | WO2000075173A2 Peptide fragments of colostrinin |
12/14/2000 | WO2000075172A2 FACTOR VIIa INHIBITORS |
12/14/2000 | CA2390090A1 Peptides |
12/14/2000 | CA2376400A1 Compounds and methods to enhance raav transduction |
12/13/2000 | EP1059302A1 Factor VIIa inhibitors |
12/13/2000 | EP1058690A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
12/13/2000 | EP1058689A1 Alpha-ketoamide inhibitors of 20s proteasome |
12/13/2000 | EP1058687A1 Nucleosides |
12/13/2000 | CN1276795A Process for purification of aspartame deriv. |
12/13/2000 | CN1276727A Growth hormone secretagogues |
12/13/2000 | CN1059436C Benzoazepine-benzooxaazepine-benzothiaazepin-N-acetate deriv. |
12/12/2000 | US6160176 Anticoagulant agents |
12/12/2000 | US6159938 Serine protease inhibitors comprising α-keto heterocycles |
12/12/2000 | CA2131186C Isosteric antiherpes peptide derivatives |
12/12/2000 | CA2058560C Trifluoromethylketone derivatives, processes for preparation thereof and use thereof |
12/12/2000 | CA2036413C Hiv protease inhibitors |
12/12/2000 | CA2036397C Hiv protease inhibitors containing derived amino acid units |
12/07/2000 | WO2000073437A1 Assays for caspase activity using green fluorescent proteins |
12/07/2000 | WO2000073341A1 Structural models for cytoplasmic domains of transmembrane receptors |
12/07/2000 | WO2000073332A1 Annexin derivatives with endogenous chelation sites |
12/07/2000 | WO2000073302A1 Oxazaheterocycles as protease inhibitors |
12/07/2000 | WO2000073266A1 Novel antioxidants, preparation methods and uses |
12/07/2000 | CA2377948A1 Annexin derivatives with endogenous chelation sites |
12/07/2000 | CA2375348A1 Novel antioxidants, preparation methods and uses |
12/07/2000 | CA2374369A1 Assays for caspase activity using green fluorescent proteins |
12/07/2000 | CA2372234A1 Oxazaheterocycles as protease inhibitors |
12/06/2000 | EP1057491A1 Preventives/remedies for skin aging |
12/06/2000 | EP1056770A1 Novel disulfides and thiol compounds |
12/06/2000 | EP1056722A1 Bisulfate salt of hiv protease inhibitor |
12/06/2000 | EP1056704A1 Antitumor agents |
12/06/2000 | CN1275912A Novel amide derivatives |
12/06/2000 | CN1275333A Process for preparation of glyconitrogen and amphoteric nitrogen mixture |
12/05/2000 | US6156903 Pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
12/05/2000 | US6156889 Reagent useful for cleaving a protected functional group |
12/05/2000 | US6156768 Alpha- and beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
12/05/2000 | US6156754 Glycoconjugates of modified camptothecin derivatives (A-or B-ring linkage) |
12/05/2000 | US6156732 A (di, tri or tetra)oligopeptide |
12/05/2000 | US6156346 Urease-responsive delivery systems for diagnostic and therapeutic applications |
12/05/2000 | CA2098921C Angiogenic peptides |
12/05/2000 | CA2026655C Process for the solubilisation of peptides and process for the synthesis of peptides |
11/30/2000 | WO2000071571A2 Fap-activated anti-tumor compounds |
11/30/2000 | WO2000071569A1 Minimal isolation peptide synthesis process using ion-exchange resins as scavenging agents |
11/30/2000 | WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS |
11/30/2000 | WO2000043413A3 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
11/30/2000 | CA2373816A1 Minimal isolation peptide synthesis process using ion-exchange resins as scavenging agents |
11/30/2000 | CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds |
11/30/2000 | CA2369933A1 Fap-activated anti-tumor compounds |
11/29/2000 | EP1055683A1 Novel acetamide derivative and use thereof |
11/29/2000 | EP1054960A1 Heteroaromatic oligoamides as affinity ligands |
11/29/2000 | EP1054892A1 Azole peptidomimetics as thrombin receptor antagonists |
11/29/2000 | EP1054891A1 Prodrugs |
11/29/2000 | EP0931069B1 Process for preparing amidines |
11/29/2000 | EP0629133B1 Peptide-metal ion pharmaceutical applications |
11/28/2000 | US6153731 Dehydrodidemnin B |
11/28/2000 | US6153613 2,3-diketopiperazine derivatives or their salts |
11/28/2000 | US6153591 Protecting nervous system following focal ischemia and global ischemia; alzheimer's disease, huntington's disease, prion diseases, parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, alopacia, rheumatoid arthritis |